7-89327355-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_181646.5(ZNF804B):āc.261A>Cā(p.Glu87Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000103 in 1,452,268 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_181646.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF804B | NM_181646.5 | c.261A>C | p.Glu87Asp | missense_variant | 3/4 | ENST00000333190.5 | NP_857597.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF804B | ENST00000333190.5 | c.261A>C | p.Glu87Asp | missense_variant | 3/4 | 1 | NM_181646.5 | ENSP00000329638 | P1 | |
ZNF804B | ENST00000611114.1 | c.12A>C | p.Glu4Asp | missense_variant | 2/3 | 5 | ENSP00000478506 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000123 AC: 3AN: 244452Hom.: 0 AF XY: 0.00000756 AC XY: 1AN XY: 132232
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1452268Hom.: 0 Cov.: 30 AF XY: 0.00000692 AC XY: 5AN XY: 722078
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2022 | The c.261A>C (p.E87D) alteration is located in exon 3 (coding exon 3) of the ZNF804B gene. This alteration results from a A to C substitution at nucleotide position 261, causing the glutamic acid (E) at amino acid position 87 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at